美股新聞 標題聯播 · 近 24 小時 305 則 · 33 個來源 · 最新 9/20 03:38
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · MRK近 30 天 24 則 · 第 1 / 1 頁
- Amgen or Merck: Which Drugmaker Has the Stronger Dividend Growth Story?
- The S&P 500 Has Returned About 11% Annually Since 1958. Here's the ETF I'd Trust for the Next 30 Years.
- 在 CHMP 支持後，默克 (MRK) 對歐盟膀胱癌治療意味著什麼？What Does Merck (MRK) Mean For EU Bladder Cancer Treatment After CHMP Support?
- What Would It Take For Eli Lilly Stock To Keep Climbing?
- Is Johnson & Johnson Stock Expensive, Or Is STELARA Hiding The Real Price?
- Merck Stock Nearly Doubled Without A Change In Its Revenue Growth
- Pfizer’s Dividend Yield Is Enormous. But Is the Payout Still Growing?
- 5 Stocks, 5 Different Industries, 1 Thing in Common: Reliable Income
- 默克獲歐盟 CHMP 正面意見，KEYTRUDA®（pembrolizumab）加 Padcev®（enfortumab vedotin-ejfv）作為可切除肌肉侵犯性膀胱癌（MIBC）成人患者圍手術期治療Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)
- 默克推出 Your Hive of Whole Health 支持 HIV 感染者的全人照護Merck Launches Your Hive of Whole Health to Support Whole Person Care for People Living With HIV
- BioNTech Threw in the Towel on Its Colorectal Cancer Vaccine Trial. Should Investors Be Worried?
- 默克 (MRK) 表現優於大盤：你需要知道的事Merck (MRK) Outperforms Broader Market: What You Need to Know
- 默克上漲，因 Keytruda 的太空研究尋求新家Merck Gains as Keytruda's Space Research Seeks a New Home
- Can Volume Keep Covering Eli Lilly's Price Cuts?
- Moderna：又一天 又一次股價大波動。癌症疫苗漲勢回來了嗎？Moderna: Another Day, Another Big Stock Move. Is the Cancer Vaccine Rally Back On?
- Moderna Climbs 6% as Cancer Vaccine Trade Extends a 137% Month; BioNTech and Novavax Edge Higher
- What Happens To AbbVie Stock If SKYRIZI Slows Down?
- 默克(MRK)正打造超越 Keytruda 特許經營權的更強未來Merck & Co. (MRK) is Building a Stronger Future Beyond Its Keytruda Franchise
- Oligonucleotide Synthesis Market Outlook 2026-2035 - Featuring Profiles of Thermo Fisher Scientific, Merck KGaA, and Integrated DNA Technologies
- Top Stock Reports for Oracle, Merck & Union Pacific
- Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $1.55B by 2031, Profiling Thermo Fisher, Bio-Techne, Merck KGaA, Danaher, Revvity, and Others
- Assessment of the Pulmonary Arterial Hypertension (PAH) Market 2026-2036 Featuring United Therapeutics, Mochida Pharmaceutical, Johnson & Johnson, Merck, and Gossamer Bio
- Merck KGaA shares rise 1.7% after HSBC upgrades stock to Buy
- SLS, IBRX Stocks In Focus: Analyst Says Moderna-Merck Cancer Vaccine Success ‘Bodes Well’ For Oncology
- Here Are Thursday’s Top Wall Street Analyst Research Calls: Alphabet, Analog Devices, Crown Castle, ebay, EPR Properties, Etsy, Merck & Co., Shopify, TJX Companies, and More
- Here Are Wednesday’s Top Wall Street Analyst Research Calls: The Gap, Genmab, Hilton Worldwide, Intuitive Surgical, Marriott International, Merck, Novo Nordisk, Okta, and More
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。